thrombosis

Ambulatory Transradial Percutaneous Coronary Intervention

Original title:&nbsp;Ambulatory Transradial Percutaneous Coronary Intervention: A Safe, Effective, and Cost-Saving Strategy.&nbsp;Reference:&nbsp;Philippe Le Corvoisier et al. Catheterization and Cardiovascular Interventions 81:15&ndash;23 (2013). The number of PCI procedures has increased and for many interventional cardiology centers PC interventions entail significant resource consumption. Reducing post procedure hospital stay could reduce costs and optimize hospitalization resources.&nbsp; The safety<a href="https://solaci.org/en/2013/01/07/ambulatory-transradial-percutaneous-coronary-intervention/" title="Read more" >...</a>

Rotational atherectomy is only an interim strategy.

Original title:&nbsp;High-Speed Rotational Atherectomy Before Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary Lesions. The Randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) Trial.&nbsp;Reference:&nbsp;Mohamed Abdel-Wahab et al. J Am Coll Cardiol Intv 2013; article in press Heavily calcified lesions are difficult and may prevent the appropriate expansion of a<a href="https://solaci.org/en/2013/01/04/rotational-atherectomy-is-only-an-interim-strategy/" title="Read more" >...</a>

Self-expanding stents improve positioning in primary angioplasty

Original title:&nbsp;Self-Expanding Versus Balloon-Expandable Stents in Acute Myocardial Infarction: Results From the APPOSITION II Study&nbsp;Reference:&nbsp;Robert-Jan van Geuns et al. J Am Coll Cardiol Intv 2012;5:1209&ndash;19 Acute myocardial infarction is associated with vasoconstriction and thrombus occlusion. Resolution of these two points during the first hours after primary angioplasty can lead to poor extension and poor positioning<a href="https://solaci.org/en/2012/12/21/self-expanding-stents-improve-positioning-in-primary-angioplasty/" title="Read more" >...</a>

Stent MGuard, primary angioplasty with a higher TIMI III

Original title:&nbsp;The MASTER Trial &#8211; Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh&ndash;Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction.&nbsp;Reference:&nbsp;Gregg W. Stone et. al. J Am Coll Cardiol 2012; 60: 1975-1984 Primary angioplasty has proven effective in restoring epicardial flow but myocardial perfusion is often suboptimal. One of the main mechanisms is distal<a href="https://solaci.org/en/2012/11/19/stent-mguard-primary-angioplasty-with-a-higher-timi-iii/" title="Read more" >...</a>

A new paradigm in the treatment of in-stent restenosis?

Original title:&nbsp;ISAR DESIRE 3: Drug-eluting balloon is best option for restenosis of limus-eluting stents&nbsp;Reference:&nbsp;Dr Robert Byrne. TCT 2012. Miami, Fl. The first of the ISAR DESIRE trials showed that drug-eluting stents (DES) were the best strategy for treating restenosis of a bare metal stent, the second ISAR DESIRE trial tested the hypothesis of changing or<a href="https://solaci.org/en/2012/11/11/a-new-paradigm-in-the-treatment-of-in-stent-restenosis/" title="Read more" >...</a>

Future second-generation stents, today.

Original title:&nbsp;First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold A Multi-Imaging Modality Study.&nbsp;Reference:&nbsp;John Ormiston et al. Circ Cardiovasc Interv. 2012;5:620-632. The first bioabsorbable stents eluting everolimus showed a 6-month delayed recoil resulting in late lumen loss of 0.44 mm, (intermediate between a metal stent<a href="https://solaci.org/en/2012/11/05/future-second-generation-stents-today/" title="Read more" >...</a>

Drug-Eluting Stents: device without polymers overcomes limitations of first generations stents

The NEXT randomized trial showed the superiority of a polymer-free amphilimus-eluting stent compared to paclitaxel-eluting stents with permanent polymers The NEXT clinical trial (International Randomized Comparison Between DES Limus Carbostent and Taxus Drug-Eluting Stents in the Treatment of De Novo Coronary Lesions), is a multicenter randomized trial (n=296) comparing coronary amphilimus eluting stent Cre8 (CID,<a href="https://solaci.org/en/2012/10/01/drug-eluting-stents-device-without-polymers-overcomes-limitations-of-first-generations-stents/" title="Read more" >...</a>

To discontinue clopidogrel after a year of infarction can be risky

Reference: Charlot et al. European Heart Journal 2012 (in press). International guideline recommendations approve giving dual antiplatelet therapy for a period of not less than 12 months after acute myocardial infarction. However, the benefit is unknown if the therapy is extended beyond 12 months. Perhaps its extension could be particularly useful in patients receiving pharmacological<a href="https://solaci.org/en/2012/10/01/to-discontinue-clopidogrel-after-a-year-of-infarction-can-be-risky/" title="Read more" >...</a>

Renal failure in acute myocardial infarction

Reference:&nbsp;Fox y colaboradores. Short-term Outcomes of Acute Myocardial Infarction in Patients with Acute Kidney Injury: A Report from the National Cardiovascular Data Registry. Circulation 2012 (in press). The presence of chronic renal failure is common in patients referred for angioplasty. Its presence is associated with increased mortality and bleeding. However, the prevalence is unknown as<a href="https://solaci.org/en/2012/09/01/renal-failure-in-acute-myocardial-infarction/" title="Read more" >...</a>

Top